Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance-Reference-Cited by-同舟云学术

Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance

Published:2019-06-13 Issue:3 Volume:38 Page:663-671
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Ploussard Guillaume^ORCID,Beauval Jean-Baptiste,Lesourd Marine,Almeras Christophe,Assoun Jacques,Aziza Richard,Gautier Jean-Romain,Loison Guillaume,Portalez Daniel,Salin Ambroise,Tollon Christophe,Soulié Michel,Malavaud Bernard,Roumiguié Mathieu

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-019-02848-x.pdf

Reference30 articles.

1. Mottet N, Bellmunt J, Bolla M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71:618–629

2. Klotz L, Vesprini D, Sethukavalan P et al (2015) Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol 33:272–277

3. Bokhorst LP, Valdagni R, Rannikko A, PRIAS study group et al (2016) A Decade of active surveillance in the PRIAS study: an update and evaluation of the criteria used to recommend a switch to active treatment. Eur Urol 70:954–960

4. Welty CJ, Cowan JE, Nguyen H et al (2015) Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer. J Urol 193(3):807–811

5. Hu JC, Chang E, Natarajan S et al (2014) Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply? J Urol 192:385–390

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel biopsy scheme for prostate cancer: targeted and regional systematic biopsy;BMC Urology;2024-04-13

2. Multiparametric magnetic resonance imaging in the active surveillance of prostate cancer: protocol, risk stratification, and surveillance;Journal of Men's Health;2024

3. Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis;European Urology Oncology;2023-08

4. Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification;European Urology;2023-04

5. Optimized grade group for reporting prostate cancer grade in systematic and MRI‐targeted biopsies;The Prostate;2022-05-10